Liver International
The tables of contents are generated automatically and are based on the data records of the individual contributions available in the index of the TIB portal. The display of the Tables of Contents may therefore be incomplete.
Table of contents
- 1783
-
Towards personalized medicine in chronic HBV patients?Sitia, Giovanni et al. | 2015
- 1786
-
Conceptual models for the initiation of hepatitis B virus‐associated hepatocellular carcinomaTu, Thomas / Budzinska, Magdalena A. / Shackel, Nicholas A. et al. | 2015
- 1801
-
Pharmacogenetic testing in idiosyncratic drug‐induced liver injury: current role in clinical practiceAithal, Guruprasad P. et al. | 2015
- 1809
-
Infusion of DDAVP does not improve primary hemostasis in patients with cirrhosisArshad, Freeha / Stoof, Sara C.M. / Leebeek, Frank W.G. et al. | 2015
- 1816
-
Cerebral white matter lesions in patients with cirrhosis – causative for hepatic encephalopathy or bystanders?Pflugrad, Henning / Bronzlik, Paul / Raab, Peter et al. | 2015
- 1824
-
An intrahepatic transcriptional signature of enhanced immune activity predicts response to peginterferon in chronic hepatitis BJansen, Louis / de Niet, Annikki / Makowska, Zuzanna et al. | 2015
- 1833
-
Plasma apolipoprotein H limits HCV replication and associates with response to NS3 protease inhibitors‐based therapySultanik, Philippe / Mallet, Vincent / Lagaye, Sylvie et al. | 2015
- 1845
-
Eligibility and safety of the first interferon‐free therapy against hepatitis C in a real‐world settingHöner zu Siederdissen, Christoph / Maasoumy, Benjamin / Deterding, Katja et al. | 2015
- 1853
-
Ketone body production is differentially altered in steatosis and non‐alcoholic steatohepatitis in obese humansMännistö, Ville T. / Simonen, Marko / Hyysalo, Jenni et al. | 2015
- 1862
-
Application of hepatocellular carcinoma surveillance in a European setting. What can we learn from clinical practice?Edenvik, Pia / Davidsdottir, Loa / Oksanen, Antti et al. | 2015
- 1872
-
Risk factors for hepatocellular carcinoma in Caucasian patients with non‐viral cirrhosis: the importance of prior obesityArchambeaud, Isabelle / Auble, Hélène / Nahon, Pierre et al. | 2015
- 1877
-
Mechanisms of fibrosis in acute liver failureHe, Yingli / Jin, Li / Wang, Jing et al. | 2015
- 1886
-
Elevated AST‐to‐platelet ratio index is associated with increased all‐cause mortality among HIV‐infected adults in ZambiaVinikoor, Michael J. / Sinkala, Edford / Mweemba, Aggrey et al. | 2015
- 1893
-
Pretransplant urinary proteome analysis does not predict development of chronic kidney disease after liver transplantationMilongo, David / Bascands, Jean‐Loup / Huart, Antoine et al. | 2015
- 1902
-
Effect of pretransplant diabetes on short‐term outcomes after liver transplantation: A National cohort studyHoehn, Richard S. / Singhal, Ashish / Wima, Koffi et al. | 2015
- 1910
-
Major depression and suicide attempts in patients with liver disease in the United StatesLe Strat, Yann / Le Foll, Bernard / Dubertret, Caroline et al. | 2015
- 1917
-
Synchronous hepatic and splenic inflammatory pseudotumour‐like follicular dendritic cell sarcomasNguyen, Ba D. / Roarke, Michael C. / Yang, Ming et al. | 2015
- 1918
-
The role of macroaggregated albumin lung perfusion scan in hepatopulmonary syndrome: are we ready to draw conclusions?Zhao, He / Tsauo, Jiaywei / Ma, Huai Y. et al. | 2015
- 1919
-
Response to ‘The role of macroaggregated albumin lung perfusion scan in hepatopulmonary syndrome: are we ready to draw conclusions?’Raevens, Sarah / Van Steenkiste, Christophe / Colle, Isabelle et al. | 2015
- 1920
-
ELF cut‐off points: aetiology is also a relevant factorFernandes, Flavia F. / Perez, Renata M. / Ferraz, Maria L. et al. | 2015
- 1921
-
Response to ELF cut‐off points: aetiology is also a relevant factorPowell, Elizabeth E. / Irvine, Katharine M. / Fagan, Kevin J. et al. | 2015
- i
-
Issue Information| 2015